<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Numerous studies have shown that <z:chebi fb="0" ids="33749">platinum compounds</z:chebi> stimulate the expression of the <z:chebi fb="0" ids="51349">polyamine</z:chebi> catabolic enzyme <z:chebi fb="0" ids="16610">spermidine</z:chebi>/<z:chebi fb="0" ids="15746">spermine</z:chebi> N(1)-acetyltransferase resulting in anti-proliferative activity and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>As many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell types including <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> cells express high levels of <z:chebi fb="0" ids="51349">polyamines</z:chebi>, the possibility to develop anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> strategies to deplete <z:chebi fb="0" ids="51349">polyamine</z:chebi> pools has drawn considerable attention in recent years </plain></SENT>
<SENT sid="2" pm="."><plain>This has been effectively accomplished by treating cells with <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> drugs in combination with <z:chebi fb="0" ids="51349">polyamine</z:chebi> analogs such as N(1),N(11)-diethylnorspermine (DENSPM) </plain></SENT>
<SENT sid="3" pm="."><plain>The present study, examined the cytotoxic effects of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> in combination with stimulators of <z:chebi fb="0" ids="51349">polyamine</z:chebi> catabolism in human <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> cells, that are notoriously resistant to chemotherapeutic treatment, and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, as protein kinase CK2 has been shown to be an anti-apoptotic and pro-survival enzyme regulated by the intracellular <z:chebi fb="0" ids="51349">polyamine</z:chebi> pools, we aimed to investigate the effect of combined DENSPM and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> treatment on CK2-<z:chebi fb="2" ids="33699">mRNA</z:chebi> and -protein levels </plain></SENT>
<SENT sid="5" pm="."><plain>Results reported here show that treatment with <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> and DENSPM in combination impairs cell viability particularly in the case of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>The analysis of CK2 expression and activity indicates that the response to a specific treatment may depend on the impact that individual compounds exert on pro-survival and pro-<z:hpo ids='HP_0011420'>death</z:hpo> proteins at the transcription and translation levels that should be carefully evaluated in view of subsequent clinical studies </plain></SENT>
</text></document>